[1]
M. Lichtenfels, “VALIDATION OF A NOVEL IN VITRO BREAST CANCER CHEMORESISTANCE PLATFORM IN NEOADJUVANT SETTING”, MAST, vol. 32, no. suppl.2, Apr. 2026.